by Grow Up Conference | Jul 14, 2023 | Cannabis News Wire, Media Partners
Past and current cannabis use still comes with a myriad of disadvantages for people in certain fields. Even though dozens of states now allow medical and recreational cannabis use, federal law still prohibits cannabis use. As a result, applicants and employees who work in certain fields or agencies often face stringent zero-tolerance drug policies that do not allow cannabis use regardless of local state law.
Professional athletes in most major sports, truck drivers and army recruits are among the classes of individuals that are subject to workplace drug tests and can face termination for failed drug tests and, in some cases, past cannabis use.
A pair of lawmakers is looking to loosen the policies on prior cannabis use for recruits in the military and people seeking security clearance. This would alleviate what the bipartisan pair of legislators call a “retirement and retainment crisis” by increasing the applicant pool for Defense Department personnel.
Every single branch of the U.S. military has struggled to meet its recruiting goals since 2022 amid record-low numbers of eligible Americans. Furthermore, experts say that of those who qualify to serve, few are willing to join the military, leading to one of the most prolific recruitment crises in U.S. history. An internal survey by the Defense Department found that only 9% of young Americans who qualify to enlist are interested in joining the military.
Representative Matt Gaetz is proposing an amendment to the National Defense Authorization Act to eliminate cannabis testing for military recruits and to allow applicants who have used cannabis in the past to join the military. Gaetz argued that past cannabis use should never exclude citizens from enlisting in the military and said that rather than penalizing them, such recruits should be embraced for stepping up to serve America.
Ret. Lt. Gen. Thomas Spoehr of the think tank Heritage Foundation said that the military has not seen such a massive recruitment shortfall since 1973 when America exited Vietnam and officially ended the draft. Army’s chief of staff, Gen. James McConville, said in 2022 that over three-quarters of U.S. adults aged 17 to 24 are disqualified from enlisting in the military largely due to drug use, obesity or criminal records, and the pool of eligible applicants shrinks each year.
Additionally, a 2022 survey by Monmouth University found that 54% of American adults have used cannabis in their lifetime. Eliminating candidates for past cannabis use effectively cuts the already-small applicant pool by one-half. In 2022 alone, close to 5,000 applicants did not make the cut due failed drug tests, an increase of 33% from 2020.
Eliminating drug-testing requirements and penalties for prior cannabis use would widen the applicant pool and allow the military to meet some of its recruitment demands in the short term.
The drug-development programs of companies such as IGC Pharma Inc. (NYSE American: IGC) could also address the needs of those who currently use marijuana for medical reasons since these formulations would be subjected to the FDA approval process, and success would mean that no one would be sanctioned for using those medicines once they can be prescribed by doctors.
NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
by Grow Up Conference | Jul 14, 2023 | Media Partners, Stratcann
New Brunswick-based cannabis producer Organigram says its net revenue and margins decreased in the third quarter of 2023 due to the declining price of cannabis flower.
The company also blamed a higher cost of sales, THC inflation, and Health Canada no longer allowing the sale of “ingestible extracts”.
Organigram had previously produced and sold Edison JOLTS, a cannabis-infused lozenge, sold in packages containing 100mg THC, ten times Health Canada’s allowed limit of 10mg THC per package. Health Canada issued a notice to cease sale and distribution of these kinds of products earlier this year.
Organigram has filed for a judicial review of Health Canada’s decision.
The company posted its third quarter results for 2023 on June 13, with net revenue down 14 percent to $32.8 million, from $38.1 million in Q3 2022.
Organigram’s cost of sales also increased to $32.3 million, from $29.4 million in the third quarter of the previous year, an increase of 10 percent.
The cannabis producer blames lower sales of its cannabis flower on “the increasingly common practice of THC-inflation” by “some licensed producers” which it says are taking part in lab shopping and selective sampling.
Citing data from High Tide’s “Cabannalytics” data program, Organigram says that the total number of SKUs in a large national retail chain of cannabis stores that were labelled as having 30% THC or higher increased ten-fold since last year, having a “profound impact” on the sales of their own cannabis flower.
Derrick West, Organigram’s Chief Financial Officer, says the company is working to increase their own THC levels to meet market demand.
“Our results for the third quarter of Fiscal 2023 were impacted by a reduction in sales in two of our higher margin categories of international sales and ingestible extracts,” said West in a company press release.
“Further, to address the impact of THC inflation, which forced us to adjust our pricing to remain competitive, we intentionally accelerated adjustments to growing conditions to increase whole flower THC levels to meet consumer demand. This temporarily reduced our flower yields, negatively impacting our margins on all flower categories.”
Despite these concerns, Organigram’s recreational net revenue was $92.5 million for the nine months ended May 31, 2023, an increase of $8 million over the same prior-year period. International sales for the first nine months of fiscal 2023 were also up considerably, nearly doubling from $9.5 million in 2022 to $18.4 million.
Image via organigram.com
by Grow Up Conference | Jul 13, 2023 | Media Partners, The New Agora

Is “Organic” Really Organic?
The Real Reason People Choose Organic Produce Over Conventional
Some pesticides currently in use were in fact developed during World War II for use in warfare.
by Arjun Walia
Is “organic” really organic? Well, no and yes. Although organic produce is not sprayed and coated with the same substances non-organic produce is, organic produce is still sprayed with biopesticides.
Biopesticides are certain types of pesticides derived from natural materials such as animals, plants, bacteria, and certain minerals. Biopesticides are a comparatively safer strategy than the use of synthetic chemical derived pesticides. They also pose low risks to humans and the environment by comparison.
The substances sprayed on conventional produce can have highly toxic cumulative effects on all life forms. Activism in this area seems to have started in the 1960’s when Rachel Carson’s 1962 book “Silent Spring” was published. It argued strongly against the use of synthetic chemicals on farms. It targeted the synthetic chemical compounds then used to kill insects and weeds.
Insecticides like DDT and herbicides like 2,4-D (an ancestor of Agent Orange) had become widely available to farmers after World War II. Between 1945 and 1972, pesticide use in the United States increased tenfold.
Carson’s book, which triggered the passage of the Environmental Protection Act in 1970, played a huge role in banning agricultural substances like DDT in 1972. Unfortunately, this dangerous growth of pesticide usage has continued to today, along with the corruption within the agencies that are tasked with monitoring the safety of these substances. We’ve seen, for example, a massive amount of corruption with regards to the approval of genetically modified foods.
Sure, organic may not be totally “organic,” but there is a good reason why many people prefer organically labelled produce. One of the main reasons is that conventional produce is sprayed with substances initially developed as nerve gas for chemical warfare:
A 2004 publication put out by the The Ontario College of Family Physicians explains,
“To understand this controversial issue it is helpful to look at the history of pesticide use. Prior to World War II, the pesticides that we use now did not yet exist. Some pesticides currently in use were in fact developed during World War II for use in warfare. The organophosphate insecticides were developed as nerve gases, and the phenoxy herbicides, including 2,4-D (the most commonly used herbicide in Canada), were created to eradicate the Japanese rice crop, and later used as a component of Agent Orange to defoliate large areas in jungle warfare. After World War II, these chemicals began to be used as pesticides in agricultural production, for environmental spraying of neighbourhoods, for mosquito eradication, and for individual home and garden use.”
There is concerning data regarding these agents. A 2019 study published in the journal Environmental Research titled, “Organic diet intervention significantly reduces urinary pesticide levels in U.S. children and adults” highlighted that diet is the primary source of pesticide exposure in both children and adults in the United States. It found that an organic diet significantly reduced neonicotinoid, OP pyrethroid, 2,4-D exposure, with the greatest reduction observed in malathion, clothianidin, and chlorpyrifos.
The researchers noted that all of us are exposed “to a cocktail of toxic synthetic pesticides linked to a range of health problems from our daily diets.” They explain how “certified organic food is produced without these pesticides,” and they ask the question, “Can eating organic really reduce levels of pesticides in our bodies?”
They tested four American families that don’t typically eat organic food to find out. All pesticides detected in the body dropped an average of 60.5% after just six days on an organic diet.
“First, we tested the levels of pesticides in their bodies on a non-organic diet for six days. We found 14 chemicals representing potential exposure to 40 different pesticides in every study participant. These included organophosphates, pyrethroids, neonicotinoids and the phenoxy herbicide 2,4-D. Some of the pesticides we found are linked to increased risk of cancer, infertility, learning disabilities, Parkinson’s, Alzheimer’s and more.”
The most significant drops occurred in a class of nerve agent pesticides called organophosphates. This class includes chlorpyrifos, a highly toxic pesticide linked to increased rates of autism, learning disabilities and reduced IQ in children.
Organophosphates are one of the most common classes of chemicals used for the control of insects on vegetables because of their high efficacy and broad spectrum of activity.They are so harmful to children’s developing brains that scientists have called for a full ban.
A study published in the British Journal of Nutrition carried out a meta-analysis based on 343 peer-reviewed publications that indicate “statistically significant and meaningful differences in composition between organic and non-organic crops/crop based foods.”
The study found that Phenolic acids are 19% higher in organic foods, Flavanones are 69% higher in organic foods (linked to reduced risk of several age-related chronic diseases), Stilbenes are 28% higher in organic foods, Flavones are 26% higher in organic foods, Flavonol is 50% higher in organic foods and Anthocyanins are 51% higher in organic foods.
Apart from the nutritional content, the study also measured concentrations of the toxic metal Cadmium (Cd), finding that in conventional foods, “significantly higher concentrations” were found. Conventional foods appear to have nearly 50 percent more of this heavy metal than organic foods. Furthermore, significant differences were also detected for other minerals and vitamins.
When it comes to pesticide residues on non-organic foods, the authors found that the volume of pesticide residues was four times higher in conventional crops.
Another study conducted by researchers from RMIT University published in the journal Environmental Research found that eating an organic diet for just one week significantly reduced pesticide exposure in adults by up to 90 percent.
At the end of the day, organic isn’t totally “organic” unless it’s grown yourself with no added pesticides. Organic used to mean completely natural, but today organic food are foods and drinks produced by methods complying with the standards of organic farming. And those standards may not be completely and totally 100 percent “organic” or natural.
It wasn’t long ago when the world’s food was completely organic, in every sense of the word. But today, most farmers have little interest in switching to the more costly and less convenient production methods required for organic certification, so this constrains the supply, which makes organic food needlessly expensive. Further, governments often subsidize conventional farming which brings down the cost.
Like anything else, there is always justification for actions that are harmful to human beings. We see it in multiple fields, and what we also see is a lack of conversation, transparency and discussion on the issue.
One side of the argument is always presented, encouraged and disseminated to the collective, while the other is ridiculed. It seems anything that is not good for business is shunned and not given the attention it deserves.
The next question is, what can we do about it? What are the solutions? The answers here often stumps me, so I’d love to hear some of your ideas in the comments section below.
Tens of thousands of subscribers
BA in Philosophy from the University of Waterloo, BEd from the University of Toronto. Writer/journalist for the past 15 years. Passionate about sharing information on a variety of topics, as you can tell!
by Grow Up Conference | Jul 13, 2023 | Cannabis News Wire, Media Partners
Cannabis banking has been one of the most contentious issues since states began legalizing medical and recreational cannabis. Although more than 30 states now allow the purchase and use of either recreational or medical cannabis, federal law still classifies cannabis as a Schedule I controlled substance.
As a result, players in the cannabis market typically cannot access financial services that are accessible to every other industry This includes access to banking institutions and federal aid, forcing businesses to operate on a cash-only basis and making it difficult for them to access capital.
Lawmakers introduced a bill called the Secure and Fair Enforcement (SAFE) Banking Act in 2019 to finally grant cannabis businesses access to financial services. However, despite being passed by the House several times, the SAFE Banking Act has consistently failed to advance past the Republican-controlled Senate.
A group of senators has now revealed that it hasn’t given up on the cannabis banking bill and is poised to vote on the banking bill in a key committee. In a recent series of interviews, several senators discussed their opinions on the controversial cannabis banking act.
Senate Banking Committee chair Sherrod Brown said that he would like to hold a committee vote on the bill after the July 6, 2023, recess. However, Brown said that the vote depends on whether unrelated legislation that had passed through his panel advances past the Senate floor. The committee held an initial hearing on the banking legislation in May and is currently debating section 10 of the proposal under the guise that it could significantly limit regulators’ ability to deal with people taking advantage of banking services.
The issue was first flagged by Senator Jack Reed, who argued that the language used in the section would make it harder for regulators to point out customers who present a risk to banking institutions, allowing for the proliferation of criminal activity in various sectors.
According to Senator Steve Daines, the cannabis banking bill still has the best chances of advancing through Congress even with Republicans holding a majority position in the House. Still, Daines noted in a separate interview that committee members still hadn’t reached a consensus on a final deal and are still holding discussions on the matter. He said that Democratic senators should limit the scope of the legislation to increase its chances of passing.
According to a spokesperson from Daines’ office, the Republican senator is open to revising the bill to add provisions for the expungement of prior cannabis-related convictions.
When marijuana banking becomes a reality, more industry companies could access the funding they need to expand their operations, and this could in turn create a bigger market for downstream businesses such as Advanced Container Technologies Inc. (OTC: ACTX).
NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
by Grow Up Conference | Jul 13, 2023 | Media Partners, Oaksterdam University
| Wensdy Von Buskirk |
June 30, 2023 |
Even though cannabis is known as “weed” and has a reputation for growing quickly and easily, cultivating high-quality cannabis plants can be quite challenging. One of the most common challenges is maintaining the correct balance of nutrients throughout the growth cycle.
Nutrient deficiencies can be disastrous for a cannabis crop, but growers with the proper training can usually reverse the effects. Oaksterdam University offers courses to help you troubleshoot your cannabis crop and ensure a high-quality yield every time.
What Happens When Cannabis Plants Have a Nutrient Deficiency?
Usually, nutrient deficiencies in cannabis plants lead to a reduced yield and subpar flower quality. When left unchecked, nutrient deficiencies can kill cannabis plants, wasting your time and money. Catching nutrient deficiencies early on is the key to a healthy, bountiful cannabis harvest.
What Are the Early Signs of Nutrient Deficiencies in Cannabis?
Growers must keep a vigilant eye on their plants to watch for these early signs of nutrient deficiencies. However, many of these symptoms can be due to multiple issues. It can be hard to pinpoint what the problem with your cannabis home grow is without training on what can go wrong.
Discolored Leaves on Cannabis Plants from Nutrient Deficiency
Healthy cannabis plants should typically have deep green leaves. Cannabis plants suffering from nutrient deficiencies often have discolored leaves. Red, brown, orange, or yellow cannabis leaves can all signal a problem with the plant and give growers a clue about what might be missing.
What Happens When Cannabis Plants Have a Nutrient Deficiency?
Usually, nutrient deficiencies in cannabis plants lead to a reduced yield and subpar flower quality. When left unchecked, nutrient deficiencies can kill cannabis plants, wasting your time and money. Catching nutrient deficiencies early on is the key to a healthy, bountiful cannabis harvest.
What Are the Early Signs of Nutrient Deficiencies in Cannabis?
Growers must keep a vigilant eye on their plants to watch for these early signs of nutrient deficiencies. However, many of these symptoms can be due to multiple issues. It can be hard to pinpoint what the problem with your cannabis home grow is without training on what can go wrong.
Discolored Leaves on Cannabis Plants from Nutrient Deficiency
Healthy cannabis plants should typically have deep green leaves. Cannabis plants suffering from nutrient deficiencies often have discolored leaves. Red, brown, orange, or yellow cannabis leaves can all signal a problem with the plant and give growers a clue about what might be missing.
by Grow Up Conference | Jul 13, 2023 | Media Partners, Stratcann
Health Canada is launching a new data-gathering program on cannabis markets in Canada that will include sampling and testing of both legal and illegal products currently in the market.
The federal agency says the new cannabis data-gathering program will allow it to “proactively collect information on the legal and illicit cannabis markets in Canada,” focusing on providing Canadians with more accurate info about cannabis health and safety risks.
The federal government has gathered data on the legal and illegal cannabis markets for several years. This approach represents a new step towards more proactive data gathering on products in the market, both licit and illicit.
As part of the program, Health Canada’s Regulatory Operations and Enforcement Branch (ROEB) Cannabis Laboratory will randomly purchase cannabis products from authorized retailers in Canada. It will also work with various law enforcement agencies to test samples of illicit cannabis products.
The lab will test for THC and CBD levels, “specific analytes of interest”, and chemical or microbiological contaminants such as pesticides, moulds, etc.
The agency will then publish reports on their findings, removing any references to product, brand or license holder names. However, if the program identifies deficiencies with any legal products they analyze, they will “take appropriate compliance and enforcement actions to mitigate health and safety risks if necessary.”
Health Canada says the program will also support the health agency’s “efforts to ensure that legal cannabis products available on the Canadian market meet the requirements set out in the act and the regulations.”
Health Canada has also begun work on guidance for licensees on cannabis products containing intoxicating cannabinoids other than delta-9-THC, and a consumer information sheet on intoxicating cannabinoids other than delta-9-THC.
Several provinces have released testing results of illicit products shared via law enforcement actions. In 2022, Ontario shared a study that showed illicit edibles have significantly less THC than advertised, and high levels of pesticides. New Brunswick and British Columbia have also released similar testing results of illicit products.
The industry has also been calling on greater oversight of THC levels in the industry.
The C-45 Quality Association, an industry group representing quality assurance professionals and others working in the cannabis industry in Canada, said the announcement is a welcome on.
“The C-45 Quality Association welcomes Health Canada’s new initiate to illuminate the cannabis industry through its new Cannabis Data Gathering Program,” said Tom Ulanowski, Board Chair for C-45. “This proactive approach will improve transparency in product composition for both legal and illicit cannabis products, assuring Canadians of the quality-controlled supply of cannabis in the regulated market. The accountability this program instills will reinforce trust in the Canadian legal cannabis industry, while the insights gathered will help us better understand and address any potential health and safety risks associated with cannabis consumption, particularly when it comes to illicit cannabis products. This is a substantial step towards a more informed and responsible cannabis marketplace in Canada.”
by Grow Up Conference | Jul 13, 2023 | Media Partners, Oaksterdam University
Even though cannabis is known as “weed” and has a reputation for growing quickly and easily, cultivating high-quality cannabis plants can be quite challenging. One of the most common challenges is maintaining the correct balance of nutrients throughout the growth cycle.
Nutrient deficiencies can be disastrous for a cannabis crop, but growers with the proper training can usually reverse the effects. Oaksterdam University offers courses to help you troubleshoot your cannabis crop and ensure a high-quality yield every time.
What Happens When Cannabis Plants Have a Nutrient Deficiency?
Usually, nutrient deficiencies in cannabis plants lead to a reduced yield and subpar flower quality. When left unchecked, nutrient deficiencies can kill cannabis plants, wasting your time and money. Catching nutrient deficiencies early on is the key to a healthy, bountiful cannabis harvest.
What Are the Early Signs of Nutrient Deficiencies in Cannabis?
Growers must keep a vigilant eye on their plants to watch for these early signs of nutrient deficiencies. However, many of these symptoms can be due to multiple issues. It can be hard to pinpoint what the problem with your cannabis home grow is without training on what can go wrong.
Discolored Leaves on Cannabis Plants from Nutrient Deficiency
Healthy cannabis plants should typically have deep green leaves. Cannabis plants suffering from nutrient deficiencies often have discolored leaves. Red, brown, orange, or yellow cannabis leaves can all signal a problem with the plant and give growers a clue about what might be missing.
What Happens When Cannabis Plants Have a Nutrient Deficiency?
Usually, nutrient deficiencies in cannabis plants lead to a reduced yield and subpar flower quality. When left unchecked, nutrient deficiencies can kill cannabis plants, wasting your time and money. Catching nutrient deficiencies early on is the key to a healthy, bountiful cannabis harvest.
What Are the Early Signs of Nutrient Deficiencies in Cannabis?
Growers must keep a vigilant eye on their plants to watch for these early signs of nutrient deficiencies. However, many of these symptoms can be due to multiple issues. It can be hard to pinpoint what the problem with your cannabis home grow is without training on what can go wrong.
Discolored Leaves on Cannabis Plants from Nutrient Deficiency
Healthy cannabis plants should typically have deep green leaves. Cannabis plants suffering from nutrient deficiencies often have discolored leaves. Red, brown, orange, or yellow cannabis leaves can all signal a problem with the plant and give growers a clue about what might be missing.
by Grow Up Conference | Jul 13, 2023 | Media Partners, Psychedelic News Wire
A recent study has found that psilocybin-assisted group psychotherapy can help alleviate the mental woes of cancer patients with depression. While several treatments are designed to kill cancer cells and alleviate the physical symptoms caused by cancer, the mental distress associated with a cancer diagnosis and treatment is rarely addressed.
Research shows that around 25% of people diagnosed with cancer suffer from depression. Cancer patients also deal with emotions such as anxiety, fear, sadness and grief, especially if they are diagnosed with particularly aggressive cancers. These psychological symptoms can cause cancer patients to become fatigued, withdrawn, lose interest in their preferred activities, and experience thinking and memory problems.
The recent study, whose findings were reported in the “Journal of Pain and Symptom Management,” shows that using psilocybin during group psychotherapy sessions may relieve some of these psychological symptoms.
Psychedelics represent a new and exciting frontier in the psychiatric field. A growing body of research has revealed that psychedelics may be able to treat various mental health disorders safely, effectively and with minimal side effects. Findings from preliminary studies have been so encouraging that institutions are investing millions of dollars into the development of psychedelic-based treatments for the mass market.
And with a significant portion of the American public currently dealing with conditions such as depression and PTSD with minimal relief from conventional treatments, psychedelics already have a large market desperate for effective therapies.
Prior studies have found that psilocybin, the main hallucinogenic agent in magic mushrooms, can be effective at treating major depressive disorder. Researchers from Johns Hopkins Medicine have found that psilocybin treatment can offer relief from depression for up to a year.
However, since most studies on the efficacy of psilocybin against depression over the long term have mostly focused on individual subjects, researchers wanted to see how the psychedelic acted in a group setting, especially in regard to an emotionally challenging and often isolating condition such as cancer. Assistant professor of psychiatry at the Huntsman Mental Health Institute at the University of Utah and study author Ben Lewis says that there are limited options for treating depression and anxiety symptoms in people diagnosed with cancer or terminal conditions.
He noted that while prior studies have provided promising results, the fact that they used individual format sessions makes access and scalability more challenging. Rather than studying individual models, Lewis’ team used a full-group model to test the efficacy, feasibility and safety of using psilocybin-assisted group therapy.
The team’s findings indicated that the group therapy was safe and well tolerated with no participants reporting any adverse effects other than from headache, hypertension and nausea in one patient. However, the researchers discovered that these symptoms were caused by viral gastroenteritis not psilocybin.
More about the therapeutic benefits of psychedelics is still being brought to light by psychedelics industry actors such as atai Life Sciences N.V. (NASDAQ: ATAI), so the world can look forward to more novel ways to use these substances for health and wellness purposes.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
by Grow Up Conference | Jul 13, 2023 | Cannabis Prospect Magazine, Media Partners
by Grow Up Conference | Jul 13, 2023 | Cannabis Prospect Magazine, Media Partners
Recent Comments